Thomas Moriarty

Thomas Moriarty

Consejero General en ALBERTSONS COMPANIES, INC. .

Fortuna: 2 M $ al 31/05/2026

62 años
Health Technology
Retail Trade
Health Services

Perfil

Thomas M.
Moriarty
currently works at Northside Center for Child Development, Inc., as Director and Albertsons Cos., Inc., as EVP-Corporate Affairs, Mergers & Acquisitions from 2025.
Mr. Moriarty also formerly worked at Red Oak Sourcing, Inc., as Chairman, Celgene Corp., as General Counsel in 2012, Merck & Co., Inc., as Assistant Counsel, CVS Health Corp., as Chief Policy & External Affairs Officer, EVP from 2017 to 2023, Medco Health Solutions, Inc., as Secretary & General Counsel from 2006 to 2012, Merial, Inc., as Assistant General Counsel-Pharma & North America, and Global Pharmaceutical Strategies, Inc., as President & Secretary.
Mr. Moriarty received his undergraduate degree in 1985 from Lafayette College and graduate degree from the University of Virginia School of Law.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
08/05/2026 138.446 ( 0,03 % ) 2 M $ 31/05/2026

Cargos activos de Thomas Moriarty

EmpresasCargoInicio
ALBERTSONS COMPANIES, INC. Consejero General 05/06/2023
Director/Miembro de la Junta -

Antiguos cargos conocidos de Thomas Moriarty.

EmpresasCargoFin
CVS HEALTH CORPORATION Public Communications Contact 13/02/2023
CELGENE Consejero General 01/09/2012
Consejero General -
Presidente -
Global Pharmaceutical Strategies, Inc.
Presidente -
Ver el detalle de la experiencia de Thomas Moriarty.

Formación de Thomas Moriarty.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

70

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Retail Trade

Health Services

Consumer Services

Health Technology

Health Services

Consumer Services

Retail Trade

Global Pharmaceutical Strategies, Inc.

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN